Allumiqs Names Derek Gooderham President
Halifax, NS – December 10, 2025 – Allumiqs is pleased to announce the appointment of Derek Gooderham as President of the Company to lead all…
Allumiqs and RayBiotech Forge Strategic Alliance to Advance Translational Biomarker Research
This collaboration bridges advanced proteomics with multiomics analytics, enabling researchers to move seamlessly from discovery to clinic.
Allumiqs Enhances Advanced Biomarker Discovery Capabilities with Alamar’s ARGO™ HT System
Allumiqs is strengthening its customer solutions with capabilities in detecting and quantifying proteins at unprecedented levels of sensitivity and accuracy.
New partnership to accelerate scientific innovation
Allumiqs is excited to announce a new strategic partnership with The Research Institute of McGill University Health Centre (The Institute), a world-renowned biomedical and healthcare…
Allumiqs Announces Derek Gooderham’s Appointment to Board of Directors
Halifax, Nova Scotia, September 16, 2024 – Allumiqs, a tech-enabled multiomics contract research organization (CRO), today announced the appointment of Derek Gooderham to its Board…
Allumiqs expands metabolomics solutions as part of the biocrates Certified Laboratory Program
Allumiqs announced today that it is now a member of the biocrates Certified Laboratory Program, becoming the only Contract Research Organization (CRO) in North America…
American Society for Mass Spectrometry 2024 Annual Conference
We’re excited to once again connect with our mass spectrometry community at ASMS 2024, June 2-6 in sunny Anaheim, CA.
Allumiqs and Prolytix form strategic partnership to accelerate drug discovery and development
Allumiqs and Prolytix, today announced their long-term, strategic partnership focused on delivering collaborative and integrated solutions to help customers optimize drug development pipelines.
PhenoSwitch Bioscience is now Allumiqs
PhenoSwitch Bioscience is now Allumiqs. For the past year we have been operating as PhenoSwitch Bioscience – A Division of Allumiqs. We are excited to…
Proteoform Scientific becomes Allumiqs Corporation
New name, expanded tools, services and solutions for biotech and biopharma